Report : North America Whole Slide Imaging Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type (Hardware, Software, and Services), Application (Telepathology, Cytopathology, Immunohistochemistry, and Hematopathology), and End User (Hospitals, Pharmaceutical and Biopharmaceutical Companies, Laboratories, and Academic Research Institutes)
At 18.4% CAGR, the North America Whole Slide Imaging Market is speculated to be worth US$ 615.72 million by 2028, says Business Market Insights
According to Business Market Insights’ research, the North America whole slide imaging market was valued at US$ 223.83 million in 2022 and is expected to reach US$ 615.72 million by 2028, registering an annual growth rate of 18.4% from 2022 to 2028. Increased utilization of artificial intelligence for better processing and outcomes and growing adoption of digital pathology.
Extensively increasing integration of medical services and digital platforms is leading to increasing popularity and acceptance of digital consultation. Artificial intelligence (AI) is one such technology, which has been reshaping the course of medical imaging and pathology in recent years. Artificial intelligence makes it much easier to utilize digitized consultation images for diagnostics as well as workflow applications. The prominent use of these digitized images is to generate diagnostic algorithms that can augment the diagnostic workflow. In addition, players are also focusing on development of AI-based products. For instance, December 2021, for breast cancer, Roche introduces three artificial intelligence (AI)-based, deep learning image analysis Research Use Only (RUO) algorithms. Artificial intelligence (AI) advances and the growing digitization of pathology are promising approaches to meet the demand for accurate detection, classification, and prediction of patients. Apart from three image analysis, the whole slide analysis workflow with automated pre-computing of the slide image before pathologist assessment and a precise visual overlay highlighting tumor cells with and without nuclear staining.
On the contrary, higher cost associated with installation and maintenance of whole slide imaging.
- Based on type, the North America whole slide imaging market is segmented into hardware, software, and services. The hardware segment held 44.8% market share in 2022, amassing US$ 99.80 million. It is projected to garner US$ 283.54 million by 2028 to expand at 19.0% CAGR during 2022–2028.
- Based on application, the North America whole slide imaging market is categorized into telepathology, cytopathology, immunohistochemistry, and hematopathology. The telepathology segment held 42.6% market share in 2022, amassing US$ 95.18 million. It is projected to garner US$ 265.16 million by 2028 to expand at 18.6% CAGR during 2022–2028.
- Based on end user, the North America whole slide imaging market is segmented into academic research institutes, hospitals, pharmaceutical and biopharmaceutical companies, and laboratories. The academic research institutes segment held 37.4% market share in 2022, amassing US$ 83.67 million. It is projected to garner US$ 232.64 million by 2028 to expand at 18.6% CAGR during 2022–2028
- Based on country, the North America whole slide imaging market has been segmented into the US, Canada, and Mexico. Our regional analysis states that the US captured 78.4% market share in 2022. It was assessed at US$ 174.94 million in 2022 and is likely to hit US$ 489.30 million by 2028, exhibiting a CAGR of 18.7% during the forecast period.
Key players dominating the North America whole slide imaging market are 3DHISTECH Ltd.; Hamamatsu Photonics K.K.; Indica Labs; Inspirata Inc.; Leica Biosystems Nussloch GmbH (Danaher); Mikroscan Technologies, Inc.; Nikon Corporation; Olympus Corporation; Visiopharm A/S; Akoya Biosciences, Inc.; and Koninklijke Philips N.V. among others.
- In May 2020, Indica Labs, and Octo, a premiere information technology systems provider to the U.S. Federal Government, are announced the online COVID Digital Pathology Repository (COVID-DPR), a virtual collection of high resolution microscopic COVID-related human tissue images hosted at the National Institutes of Health. COVID-DPR is underpinned by Indica Labs’ HALO Link software.
- In September 2020, Inspirata announced a multi-year partnership with TriCore Reference Laboratories. TriCore will leverage Dynamyx’s fully integrated workflows with the lab’s existing APLIS.
Contact Person: Sameer Joshi
Email Id: email@example.com